News
bioMérieux received nine 2025 IMV ServiceTrak™ Clinical Laboratory Awards for excellence in Immunoassay Analyzers, ID/AST Systems, Molecular Diagnostics and Blood Culture Systems.
Swipe to discover more
-
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
Oxford Nanopore Technologies and bioMérieux have announced the launch of AmPORE-TB, a Research Use Only (RUO) solution for the rapid characterization of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore sequencing technology. -
Two Hours Saved, Antibiotics Reduced: The Strong Case for a Novel Rapid Multiplex PCR in the ED
The Academic Emergency Medicine journal has published a study that investigates the effectiveness of a rapid (approximately 15–minute turnaround) 15-plex PCR respiratory panel in emergency department (ED) patients with suspected ARI. Below we summarize the key findings.
-
bioMérieux publishes a Bioethics Charter: A first in the diagnostics sector
bioMérieux confirms its ethical commitment to clinical research through a Bioethics Charter that guarantees transparency, accountability, and respect for human dignity. In particular, it aims to protect research participants when collecting and using biological samples and personal data.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19